Expanded Access for Marizomib

Celgene

Status

Conditions: Solid Tumor

Treatments: Drug: Marizomib

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT04644107

Marizomib

Details and patient eligibility

About

This is an expanded access program (EAP) for eligible participants designed to provide access to Marizomib.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria